Utilization of Colistin Versus β-Lactam and β-Lactamase Inhibitor Agents in Relation to Acute Kidney Injury in Patients with Severe Gram-Negative Infections

INTRODUCTION: Colistin is used to treat severe antibiotic-resistant Gram-negative infections (GNIs). With the rise of antibiotic resistance, colistin has been used increasingly as a ‘last-line’ therapy for multidrug-resistant GNIs. We evaluated the incidence of acute kidney injury (AKI) and mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Doremus, Casey, Marcella, Stephen W., Cai, Bin, Echols, Roger M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564277/
https://www.ncbi.nlm.nih.gov/pubmed/34731456
http://dx.doi.org/10.1007/s40121-021-00556-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564277/
https://www.ncbi.nlm.nih.gov/pubmed/34731456
http://dx.doi.org/10.1007/s40121-021-00556-x

Ejemplares similares